Karstadt Myra
Drexel University, School of Public Health, Philadelphia, USA.
Int J Occup Environ Health. 2010 Jan-Mar;16(1):89-96. doi: 10.1179/107735210800546092.
Despite poor-quality toxicity tests, acesulfame potassium was approved by the US Food and Drug Administration (FDA) for use as an artificial sweetener. At present, acesulfame is very widely used, most frequently in blends with the most popular artificial sweetener in the US, sucralose (Splenda). Acesulfame was nominated twice (in 1996 and again in 2006) for testing in the National Toxicology Program (NTP) bioassay program. Both nominations were rejected by NTP. Rather than carry out bioassays, NTP subjected acesulfame to tests in genetically modified mice (GMM). Those GMM tests yielded results that provided no insight into potential carcinogenicity of acesulfame. It is possible that FDA discouraged NTP from conducting bioassays of acesulfame. Acesulfame should be tested in the bioassay program as soon as possible, and steps should be taken to ensure the objectivity of the bioassay nomination process.
尽管毒性测试质量不佳,乙酰磺胺酸钾仍被美国食品药品监督管理局(FDA)批准用作人工甜味剂。目前,乙酰磺胺酸钾应用非常广泛,最常与美国最受欢迎的人工甜味剂三氯蔗糖(Splenda)混合使用。乙酰磺胺酸钾曾两次(1996年和2006年)被提名为国家毒理学计划(NTP)生物测定计划的测试对象。这两次提名均被NTP拒绝。NTP没有进行生物测定,而是对转基因小鼠(GMM)进行了乙酰磺胺酸钾测试。这些转基因小鼠测试结果未能提供有关乙酰磺胺酸钾潜在致癌性的见解。有可能是FDA阻止了NTP对乙酰磺胺酸钾进行生物测定。应尽快在生物测定计划中对乙酰磺胺酸钾进行测试,并应采取措施确保生物测定提名过程的客观性。